Ambient
Showing 131851–131900 of 146725 results
-
SARS-CoV-2 Spike protein RBD-HRP, BA.2 variant, His Tag
BA.2 differs from BA.1 in its genetic sequence, including some amino acid differences in the spike protein and other proteins. Studies have shown that BA.2 has a growth advantage over BA.1. Studies are ongoing to understand the reasons for this growth advantage, but initial data suggest that BA.2 appears inherently more transmissible than BA.1, which currently remains the most common Omicron sublineage reported. This difference in transmissibility appears to be much smaller than, for example, the difference between BA.1 and Delta. Further, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages (BA.1 and BA.1.1), there is still a reported decline in overall cases globally.
-
SARS-CoV-2 Spike protein RBD-HRP, BA.2 variant, His Tag
BA.2 differs from BA.1 in its genetic sequence, including some amino acid differences in the spike protein and other proteins. Studies have shown that BA.2 has a growth advantage over BA.1. Studies are ongoing to understand the reasons for this growth advantage, but initial data suggest that BA.2 appears inherently more transmissible than BA.1, which currently remains the most common Omicron sublineage reported. This difference in transmissibility appears to be much smaller than, for example, the difference between BA.1 and Delta. Further, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages (BA.1 and BA.1.1), there is still a reported decline in overall cases globally.
-
SARS-CoV-2 Spike protein RBD-HRP, BA.2 variant, His Tag
BA.2 differs from BA.1 in its genetic sequence, including some amino acid differences in the spike protein and other proteins. Studies have shown that BA.2 has a growth advantage over BA.1. Studies are ongoing to understand the reasons for this growth advantage, but initial data suggest that BA.2 appears inherently more transmissible than BA.1, which currently remains the most common Omicron sublineage reported. This difference in transmissibility appears to be much smaller than, for example, the difference between BA.1 and Delta. Further, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages (BA.1 and BA.1.1), there is still a reported decline in overall cases globally.
-
SARS-CoV-2 Spike protein RBD-HRP, BA.2 variant, His Tag
BA.2 differs from BA.1 in its genetic sequence, including some amino acid differences in the spike protein and other proteins. Studies have shown that BA.2 has a growth advantage over BA.1. Studies are ongoing to understand the reasons for this growth advantage, but initial data suggest that BA.2 appears inherently more transmissible than BA.1, which currently remains the most common Omicron sublineage reported. This difference in transmissibility appears to be much smaller than, for example, the difference between BA.1 and Delta. Further, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages (BA.1 and BA.1.1), there is still a reported decline in overall cases globally.
-
SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein S1, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike protein S1, Omicron Variant, His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
-
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
-
SARS-CoV-2 Spike S1 Antibody (hIgA2001), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
-
SARS-CoV-2 Spike S1 Antibody (hIgA2001), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
-
SARS-CoV-2 Spike S1 Antibody (hIgM2001), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
-
SARS-CoV-2 Spike S1 Antibody (hIgM2001), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
-
Sarsasapogenin
Molecular Formula : C27 H44 O3
-
Sarsasapogenin
Molecular Formula : C27 H44 O3
-
Sassafras Oil, Natural (DEA List I Chemical)
Sassafras Oil, Natural (DEA List I Chemical)
-
Sassafras Oil, Natural (DEA List I Chemical)
Sassafras Oil, Natural (DEA List I Chemical)
-
Sassafras Oil, Natural (DEA List I Chemical)
Sassafras Oil, Natural (DEA List I Chemical)
-
Sassafras Oil, Natural (DEA List I Chemical)
Sassafras Oil, Natural (DEA List I Chemical)
-
Saterinone
Molecular Formula : C27H30N4O4
-
Satisfar
Molecular Formula : C10 H17 N2 O4 P S
-
Satisfar
Molecular Formula : C10 H17 N2 O4 P S
-
Savolitinib
Molecular Formula : C17H15N9
-
Savolitinib
Molecular Formula : C17H15N9
-
Savolitinib
Molecular Formula : C17H15N9
-
Savory Oil, Summer Variety
Savory Oil, Summer Variety
-
Savory Oil, Summer Variety
Savory Oil, Summer Variety
-
Savory Oil, Summer Variety
Savory Oil, Summer Variety
-
Saxagliptin Hydrate
Molecular Formula : C18 H25 N3 O2 . H2 O
-
Saxagliptin Hydrate
Molecular Formula : C18 H25 N3 O2 . H2 O
-
Saxagliptin Hydrochloride
Molecular Formula : C18 H25 N3 O2 . Cl H
-
Saxagliptin Hydrochloride
Molecular Formula : C18 H25 N3 O2 . Cl H
-
Saxagliptin Hydrochloride
Molecular Formula : C18 H25 N3 O2 . Cl H
-
Saxagliptin O-Beta-D-glucuronide
Molecular Formula : C24H33N3O8
-
Saxagliptin O-Beta-D-glucuronide
Molecular Formula : C24H33N3O8
-
Saxagliptin O-Sulfate
Molecular Formula : C18H25N3O5S
-
Saxagliptin O-Sulfate
Molecular Formula : C18H25N3O5S
-
SB 202190
Molecular Formula : C20H14FN3O
-
SB 202190
Molecular Formula : C20H14FN3O
-
SB 202190
Molecular Formula : C20H14FN3O
-
SB 202474
Molecular Formula : C17H17N3O
-
SB 203580 Hydrochloride
Molecular Formula : C21H16FN3OS . HCl
-
SB 203580 Hydrochloride
Molecular Formula : C21H16FN3OS . HCl
-
SB 203580 Hydrochloride
Molecular Formula : C21H16FN3OS . HCl
-
SB 204741
Molecular Formula : C14H14N4OS